Trial intelligence / Profile preview

Phase 3 trial of bendamustine in Japan

jRCT2080225172Phase 3Completed

Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of bendamustine. Started Apr 2020; status: completed.

02

Drugs

bendamustine

Beyond the preview

Go deeper on jRCT2080225172.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080225172.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call